Showing results (331-340 of 832) with videos related to

Sort By:
Pageof 84
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|July 7, 2011
Experimental testing of skin reactions to insulin detemir in diabetes patients naïve to insulin detemirKenichiro O'goshi, Jørgen Serup, Bente Blaaholm, et al.
Nephron|July 13, 2022
Can the Use of Continuous Glucose Monitoring Improve Glycemic Control in Patients with Type 1 and 2 Diabetes Receiving Dialysis?Tobias Bomholt, Dea Kofod, Kirsten Nørgaard, et al.
Redox Biology|July 1, 2017
Urinary albumin and 8-oxo-7,8-dihydroguanosine as markers of mortality and cardiovascular disease during 19 years after diagnosis of type 2 diabetes - A comparative study of two markers to identify high risk patientsKasper Broedbaek, Rasmus Køster-Rasmussen, Volkert Siersma, et al.
Clinical Epidemiology|November 16, 2016
The Danish Adult Diabetes RegistryMarit Eika Jørgensen, Jette K Kristensen, Gitte Reventlov Husted, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|February 25, 2025
Long Term Outcomes After Flexor Tendon Tenotomy of the Diabetic FootJonas Askø Andersen, Anne Rasmussen, Marie Frimodt-Møller, et al.
Blood Pressure Monitoring|July 9, 2015
Cuff inflations do not affect night-time blood pressure: comparison of 24 h ambulatory blood pressure measured by a cuff and a tonometric device in type 2 diabetesEmilie H Petersen, Simone Theilade, Tine W Hansen, et al.
European Journal of Endocrinology|March 9, 2016
suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal diseaseSimone Theilade, Peter Rossing, Jesper Eugen-Olsen, et al.
Diabetes Research and Clinical Practice|June 21, 2016
Retinopathy is associated with impaired myocardial function assessed by advanced echocardiography in type 1 diabetes patients - The Thousand & 1 StudyNina Nouhravesh, Henrik U Andersen, Jan S Jensen, et al.
Therapeutic Advances in Endocrinology and Metabolism|July 25, 2022
The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practiceBernt Johan von Scholten, Frederik Flindt Kreiner, Søren Rasmussen, et al.
The Lancet. Diabetes & Endocrinology|February 10, 2015
Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trialDick de Zeeuw, Deborah A Anzalone, Valerie A Cain, et al.
Pageof 84